Cell type cancer that has material basis in abnormally proliferating cells derives from epithelial cells.
1
Purpose: Resistance to platinum chemotherapy remains a significant problem in ovarian carcinoma.
2
However, when ductal carcinoma involves large cysts, surgical treatment may be difficult.
3
Conclusions: This report represents the first documented case of mixed corticomedullary carcinoma.
4
Purpose: To report a case of isolated squamous cell carcinoma of cornea.
5
Background: The treatment outcome of advanced stage uterine cervical carcinoma remains unsatisfactory.
1
Warren pictures a case of noli-me-tangere, a destructive type of epithelial carcinoma.
2
Background & objective: The postoperative chemotherapy for ovarian epithelial carcinoma need to be improved.
3
This study was conducted to seek suitable chemotherapy for patients with stage II-IV ovarian epithelial carcinoma.
4
Conclusions: We recommend 5-6 cycles of CP-based chemotherapy regimens for stage II-IV ovarian epithelial carcinoma.
5
The tumor had the typical cribriform pattern of ACC, lacked any component of surface epithelial carcinoma, and showed myoepithelial differentiation.
6
The clpE mutant also showed substantially reduced adherence to the human lung epithelial carcinoma A549 cell line and human umbilical-vein-derived endothelial cells.
7
Methods: A single-institution, phase II study was performed in women with recurrent ER+ epithelial carcinoma of the ovary or peritoneum.
8
We therefore propose that stimulation or dysfunction of purinergic receptors may contribute at least partially to modulation of epithelial carcinoma cell proliferation and apoptosis.
9
We are the first to report the presence of a hemato- epithelial cancer compartment, which contributes to stem cell markers and CXCR4 in epithelial carcinoma.
10
Borderline tumours are less aggressive than epithelial carcinomas, with an indolent clinical course and delayed recurrence.
11
Although common in hematologic and mesenchymal malignancies, recurrent gene fusions have not been well characterized in epithelial carcinomas.
12
The tumor antigen 5T4 is frequently expressed at high levels on renal cell carcinoma (RCC) and other epithelial carcinomas.